ICICI Prudential Life

INDUSTRY INSURANCE CMP (as on 24 Apr 2018) Rs 418 Target Price Rs 515 Nifty 10,614 Sensex 34,617 KEY STOCK DATA Bloomberg IPRU IN No. of Shares (mn) 1,435 MCap (Rs bn) / ($ mn) 600/9,054 6m avg traded value (Rs mn) 536 STOCK PERFORMANCE (%) 52 Week high / low Rs 507/363 3M 6M 12M Absolute (%) (3.8) 7.4 4.4 Relative (%) 0.5 1.2 (12.3) SHAREHOLDING PATTERN (%) Promoters 80.7 FIs & Local MFs 3.8 FPIs 6.5 Public & Others 9.0 Source : BSE Madhukar Ladha madhukar.ladha@hdfcsec.com +91-22-6171-7323 Stellar Margins ICICI Pru Life delivered a strong set of numbers of 4Q. Higher share of protection, operating efficiency and lower tax rate drove its full year margin to 16.5% (9M: 13.7%). With this margin, ICICI Pru has narrowed margin gap with competitors despite higher share of ULIPs (VNB Margins- HDFC Life: 23.2%; SBI Life: 16%, Max Life: 18.5%). 4Q APE came in at Rs.22.1bn (+2.1% YoY); growth was subdued on higher base and as new business premium declined in Jan and Feb 18. For, IPRU recorded New Business and Renewal Business premiums of Rs96.2bn (+17.1%) and Rs77.9bn (+23.1% YoY) respectively. For, savings and protection APE grew 71.5% and 15.4% respectively resulting in the share of protection improving 180bps to 5.7%. Strong improvement in margin resulted in VNB increasing 93.1% in to Rs 12.9bn. PAT for the quarter was down 16.4% YoY at Rs 3.4bn due to high new business strain and negative investment income. We upgrade our margin assumptions resulting in VNB increasing by 19.9/19.7% RESULTS REVIEW 4Q 25 APR 2018 ICICI Prudential Life BUY for FY19/20. We continue to like ICICI Pru Life as it benefits from financialization of savings and further margin levers. We maintain BUY with an increased TP of Rs 515 (FY20 EV+ 25x FY20E VNB). Highlights of the quarter Management highlighted increase in margin for doesn t have any one offs (while change in tax rate does provide a bump up to margins it is recurring in nature) and expects further improvements in margins as share of protection increases and persistency sustains in all the buckets. For contribution of ULIP is 81.9% compared to 84.1% in. 13 th persistency (without single premium) improved to 86.9% in 11M from 84.7% (). ROEV for stood at 23.4% compared to 16.5% in as lower tax rate boosted operating variance. AUM increased 0.8% QoQ to Rs 1.4tn with 47% Equity mix. Near-term outlook: We expect premium growth to improve. Business Summary (Rs bn) 4Q 4Q YoY (%) 3Q QoQ (%) E FY19E FY20E NBP 29.92 25.60 16.9 23.17 29.1 78.6 96.2 104.4 124.0 APE 22.13 21.67 2.1 20.05 10.4 65.0 77.9 90.6 108.6 VNB NM NM NM NM NM 6.7 12.9 15.9 19.8 VNB Margin (%) 16.5# 10.3# 640bps 13.7# NM 10.3 16.5 17.5 18.3 EV 161.8 187.9 211.8 241.0 MCap/EV (x) 3.81 3.25 2.88 2.53 P/Bv (x) 10.06 8.76 7.67 6.77 ROEV 20.6 23.4 18.0 18.8 # Refers to and margins respectively HDFC securities Institutional Research is also available on Bloomberg HSLB <GO>& Thomson Reuters

Protection APE showed stellar growth of ~71% in VNB Margin improved from 10.1% for to 16.5% for. This improvement was largely as a result of change in product mix (higher protection business and more profitable savings products). Company has not yet changed its persistency assumptions despite seeing improvements in the same. It is waiting for sustained improvements in all cohorts. Concall highlights Business ICICI Pru Life continues to focus on customer centric products. While business growth for the quarter (APE +2.1% YoY) looks muted due to high base, over the last 1/3/5yrs, the company has delivered APE growth of 17.6/18.0/17.1%. Renewal premium at Rs175bn was up +23.1% for. Protection has grown strongly at 71% for ; credit life, within protection, has grown the fastest. Protection has contributed 40% to retail business policies issued. 13th persistency, one of the most important parameter for quality of business, has continued to improve and come in at 87.8%; Persistency excluding single premium has also improved for all cohorts. IPRU is using technology to drive superior customer experience cost efficiencies; Currently 64% of policies are issued within 2 days. Company currently has 252% solvency while the regulatory requirement is 150%. As the company grows its capital consuming protection business it may stop paying special dividend in order to conserve capital. Embedded Value and VNB VNB margin has shown strong improvement from 10.1% in to 16.5% in. A 400bps improvement in VNB is attributed to change in product mix i.e. higher protection mix, along with better product features. Product mix and changed features have resulted in better margins. For 9M, the company had reported VNB margin of 13.7%. Other components in VNB margin improvement have been positive expense experience +1.1% and other assumption changes (excluding expenses) of 1.3%. Savings margin is improving also as a result of improving cost efficiencies in assumptions; Company is now using effective tax rate instead of chargeable tax rate. Similar change in VNB resulted in 130bps (most of it) YoY margin improvement. Non-commission based cost has reduced resulting in lower sensitivity of acquisition cost factor to VNB; Improved profitability has also helped sensitivity. ICICI Pru Life has not made any material change in the persistency assumption and continues to remain conservative on this front. It wants to change assumption in a material way only after all cohorts show sustained improvement. A Rs 7.64 bn positive variance in the operating assumption is largely owing to tax related change and is non recurring. Future margin levers: Higher share of Protection, improvement in persistency and cost efficiency would drive further improvement in margins and will also increase EV. Business Outlook Protection business is expected to grow faster than rest of the portfolio. This can further enhance VNB margins. The company is not targeting any specific product mix. Page 2

Five Quarters At A Glance (Rs Bn) 4Q 1Q 2Q 3Q 4Q YoY(%) QoQ(%) Growth Growth Premium Earned 75.79 48.85 65.99 68.56 87.29 15.2 27.3 Premium on re-insurance 0.53 0.65 0.59 0.61 0.73 37.7 19.7 Net premium earned 75.26 48.2 65.4 67.95 86.56 15.0 27.4 Investment income 67.48 36.19 29.83 67.6-13.66-120.2-120.2 Other income 0.42 0.16 0.17 0.18 0.24-42.9 33.3 Total Income 143.16 84.55 95.4 135.73 73.14-48.9-46.1 Commission Paid 2.51 2.17 3.63 3.77 4.46 77.7 18.3 Expenses 8.35 5.3 6.46 6.83 7.78-6.8 13.9 Tax on policyholder funds 0.19 0.26 0.23 0.24 0.47 147.4 95.8 claim/benefits paid 49.02 39.69 40.71 46.85 45.56-7.1-2.8 change in actuarial liability 78.79 32.85 39.88 73.23 11.25-85.7-84.6 Total outgo 138.86 80.27 90.91 130.92 69.52-49.9-46.9 PBT 4.3 4.28 4.49 4.81 3.62-15.8-24.7 Tax on 0.22 0.22 0.28 0.29 0.21-4.5-27.6 PAT 4.08 4.06 4.21 4.52 3.41-16.4-24.6 New Business Premium 25.60 20.34 22.80 23.17 29.92 16.9 29.1 Total APE 21.67 17.04 18.70 20.05 22.13 2.1 10.4 -Savings APE 20.80 16.27 17.96 19.26 19.96-4.0 3.6 -Protection APE 0.86 0.77 0.73 0.80 2.16 151.2 170.0 Savings APE Share (%) 96.0 95.5 96.1 96.0 90.2-579bps -582bps Protection APE Share (%) 4.0 4.5 3.9 4.0 9.8 579bps 582bps Cost to Total Premium (%) 14.3 13.1 13.1 13.2 14.5 13bps 121bps VNB Margin (%)# 10.1 16.5 16.5 16.5 16.5 640bps NA Strong growth in protection business as seen in the changing mix. Partly also as a result of re-classification. Sharp increase in margins driven by product mix, persistency and lower tax rate assumption. AUM Rs (bn) 1229.19 1265.91 1305.91 1383.04 1395.32 13.5 0.9 Equity Mix (%) 46.8 46.5 46.0 48.0 47.0 +20bps -100bps Debt Mix (%) 53.2 53.5 54.0 52.0 53.0-20bps +100bps Linked (%) 71.5 71.3 70.7 71.0 NA NA NA Non-Linked (%) 28.5 28.7 29.3 29.0 NA NA NA #Refers to 9M and 9M margin; for 4Q is refers to margin Page 3

93% jump in YoY NBV in. (Rs Mn) FY16 E Opening IEV 138,244 139,390 161,840 Value of New Business 4,123 6,660 12,860 Expected return on existing business 17,072 16,290 23,940 IEV operating earnings 21,195 22,950 36,800 Economic variances From actual return in excess of expected real-world return -6,159 5,820 1,120 From change in economic assumption 524 na Na Other non-operating variances Total IEV earnings 15,560 28,770 37,920 Capital contributions / dividend payouts -14,414-6,320-11,880 Closing adjustments Closing IEV-Year End 139,390 161,840 187,880 ROEV return % 11.3% 20.6% 23.4% APE 51,085 64,965 77,920 VNB Margin 8.1% 10.3% 16.5% ICICI Pru Life % chg in VNB % chg in EV % chg in VNB % chg in EV Reference rate up 100 bps -5.2-2 -4.9-2.1 Reference rate down 100 bps 5.5 2.1 5.2 2.2 Lapse/Surrender rate up 10 % -10.6-1.1-8.6-1.3 Lapse/Surrender rate down 10 % 10.9 1.2 9.1 1.4 Maintenance expenses up 10 % -5.5-1.1-3.5-1.0 Maintenance expenses down 10 % 5.4 1.1 3.5 +1.0 Mortality up 10 % -6.1-0.8-5.4-1.0 Mortality down 10 % 6.1 0.8 5.5 1.0 Tax Rate increased to 25%/28.84%* -22% -11% -7.9-4.6 Tax Rate increased to 34.6% -5.2-2 NA NA Page 4

APE growth was muted at 2.1% YoY. Protection business share improving is hugely beneficial for the company s margins. APE trend ( Rs bn.) Rs bn Total APE 90 80 70 60 50 40 30 20 10 0 FY16 1Q 2Q Growth - RHS 3Q 4Q 120.0 100.0 80.0 60.0 40.0 20.0 0.0 Product Mix On APE -ULIP -PAR -Non-PAR -Group Protection 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% FY16 Margin has seen a strong improvement on change in tax assumption, higher share of protection business and lower cost assumptions. VNB Trend( Rs bn.) Rs bn VNB 14.00 12.00 10.00 8.00 6.00 4.00 2.00 VNB Margin - RHS 18.0% 16.0% 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% AUM Mix 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Equity Debt 0.00 FY16 0.0% FY16 1Q 2Q 3Q Page 5

Persistency Trend Channel Mix On APE Persistency has been improving across all buckets except for 61 st 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 13th FY15 FY16 25th 37th 49th 61st Bancassurance Agency Direct Corporate Agents Group 100% 80% 60% 40% 20% 0% FY16 1Q 2Q 3Q 4Q We have changed our margin assumptions resulting in significant increase in our VNB and EV projections. Change In Estimates Rs bn FY19E FY20E New Old Change(%) New Old Change(%) APE 90,609 90,609 0% 108,609 108,609 0% VNB 15,860 13,230 19.9% 19,826 16,565 19.7% VNB Margin (%) 17.5% 14.6% 290bps 18.3% 15.3% 300bps Embedded Value 211,827 197,813 7% 241,122 221,244 9.0% Source: HDFC sec Inst Research Peer Comparison Rs Bn Mcap (Rs bn) CMP (Rs) Reco TP VNB EV P/EV (x) VNB Multiple (x) APE GROWTH (%) VNB Margin (%) E FY19E FY20E E FY19E FY20E E FY19E FY20E E FY19E FY20E E FY19E FY20E E FY19E FY20E HDFC Life# 1,006 503 NR NR 13.07 16.55 20.97 147.40 176.38 212.23 6.82 5.70 4.74 65.7 50.1 37.9 43.1 22.0 19.0 22.4 23.2 24.7 SBI Life 754 754 BUY 810 14.3 18.3 22.8 194.0 228.8 270.8 3.89 3.30 2.78 39.1 28.7 21.2 37.6% 25.6% 23.7% 15.8 16.0 16.2 ICICI Pru Life 600 418 BUY 515 10.5 13.5 17.1 178.5 198.7 222.9 3.49 3.14 2.79 42.4 31.5 23.4 17.3% 21.8% 19.9% 13.8 14.5 15.4 Max Financial 136 507 BUY 665 6.1 7.5 9.1 74.4 84.3 96.3 2.61 2.31 2.02 19.6 14.8 10.8 16.7% 19.4% 19.4% 19.1 19.5 19.8 Source: Companies, HDFC Sec Inst Research, * For Max Life, #Consensus Estimates for HDFC Life Page 6

Policyholder AC (Rs mn) FY19E FY20E Total Premium earned 221,552 267,594 313,063 369,643 Income from investments and other income 150,360 114,199 141,031 163,163 Transfer from shareholders AC 18 - - - Total Income 371,930 381,792 454,095 532,805 Commission 7,589 8,950 10,523 12,441 Operating expenses 23,572 27,717 32,116 37,554 Provisions 4,288 4,501 4,725 4,960 Total Expenses 35,450 41,168 47,365 54,955 Benefits Paid 149,979 172,770 189,403 218,521 Change in valuation of liabilities 174,976 154,226 200,688 241,498 Total 324,954 326,996 390,091 460,019 Surplus 11,527 13,628 16,639 17,831 Tax 788 932 998 1,159 Net Surplus 10,738 12,696 15,641 16,672 Transfer to shareholders AC 11,315 11,680 14,077 14,505 Shareholders AC (Rs mn) E FY19E FY20E Transfer from policyholders' a/c 11,315 11,680 14,077 14,505 Investment income 6,932 6,641 7,552 8,560 Total income 18,248 18,321 21,629 23,065 Expenses 380 408 439 472 Contribution to policyholders' a/c 18 - - - Profit before tax 17,850 17,913 21,190 22,593 Taxes 1,028 1,164 1,377 1,469 PAT 16,822 16,749 19,813 21,125 Page 7

Key Ratios In % E FY19E FY20E Premium Growth 16.6 40.8 17.0 18.1 NBP Growth 16.2% 22.4% 8.5% 18.8% APE Growth 27.2% 19.8% 16.3% 19.9% Commissions Growth 22.4 44.4 17.6 18.2 Opex Growth 24.8 46.8 15.9 16.9 Commissions / premium 3.4 3.3 3.4 3.4 Opex / premium 10.6 10.4 10.3 10.2 PAT Growth 1.7 1.2 18.3 6.6 RoAA 1.5 1.4 1.3 1.2 RoE 30.0 27.8 26.5 24.9 EPS (Rs) 11.72 11.67 13.80 14.72 BV (Rs) 42.7 48.6 55.5 62.8 DPS (Rs) 3.8 4.9 5.8 6.1 EV (Rs mn) 161,840 187,880 211,827 241,122 VNB (Rs mn) 6,660 12,860 15,860 19,826 EVOP (Rs mn) 22,950 36,800 33,854 39,858 ROEV 20.6 23.4 18.0 18.8 P/E (x) 36.7 36.5 30.8 28.9 P/ABV (x) 10.06 8.76 7.67 6.77 P/EV (x) 3.81 3.25 2.88 2.53 P/NBV (x) 68.4 32.9 25.2 18.6 Balance Sheet (Rs mn) E FY19E FY20E Source Share capital 14,353 14,353 14,353 14,353 Reserve and surplus 46,996 55,370 65,277 75,839 Net worth 61,350 69,724 79,630 90,193 Credit/debit balance in fair value a/c 2,731 2,731 2,731 2,731 Policyholders' a/c 1,148,941 1,303,167 1,503,855 1,745,352 Funds for future appropriation 6,042 6,785 6,954 7,128 Total Liabilities 1,219,063 1,382,406 1,593,170 1,845,404 Application Shareholders' Investments 66,403 75,520 85,596 96,332 Policyholders' investments 270,674 - - - Asset to cover linked liabilities 878,783 1,303,683 1,504,371 1,745,869 Loans 806 806 806 806 Fixed assets + DTA 2,138 2,138 2,138 2,138 Net current assets 259 259 259 259 Debit balance in P&L - - - - Total Assets 1,219,063 1,382,406 1,593,170 1,845,404 Page 8

RECOMMENDATION HISTORY ICICI Pru Life 600 550 500 450 400 TP Date CMP Reco Target 28-Dec-17 390 BUY 465 22-Jan-18 430 BUY 480 10-Apr-18 397 BUY 465 25-Apr-18 418 BUY 515 350 300 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 Rating Definitions BUY : Where the stock is expected to deliver more than 10% returns over the next 12 period NEUTRAL : Where the stock is expected to deliver (-)10% to 10% returns over the next 12 period SELL : Where the stock is expected to deliver less than (-)10% returns over the next 12 period Page 9

Disclosure: I, Madhukar Ladha, CA, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest. Any holding in stock No HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475. Disclaimer: This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published for any purposes without prior written approval of HSL. Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve s. HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve s from t date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business. HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report. HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600 HDFC Securities Limited, SEBI Reg. No.: NSE-INB/F/E 231109431, BSE-INB/F 011109437, AMFI Reg. No. ARN: 13549, PFRDA Reg. No. POP: 04102015, IRDA Corporate Agent License No.: HDF 2806925/HDF C000222657, SEBI Research Analyst Reg. No.: INH000002475, CIN - U67120MH2000PLC152193 Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing. Page 10

HDFC securities Institutional Equities Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park, Senapati Bapat Marg, Lower Parel, Mumbai - 400 013 Board : +91-22-6171 7330 www.hdfcsec.com Page 11